Showing 101,401 - 101,420 results of 112,217 for search '(( 12 m decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.90s Refine Results
  1. 101401

    Effects of Whole Grain, Fish and Bilberries on Serum Metabolic Profile and Lipid Transfer Protein Activities: A Randomized Trial (Sysdimet) by Maria Lankinen (208497)

    Published 2014
    “…</p><p>Methods</p><p>Altogether 131 subjects (40–70 y, BMI 26–39 kg/m<sup>2</sup>) with impaired glucose metabolism and features of the metabolic syndrome were randomized into three groups with 12-week periods according to a parallel study design. …”
  2. 101402

    Table_2_Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations.XLSX by Li Yang (6520)

    Published 2019
    “…</p><p>Methods: Next generation of sequencing (NGS) and clinical data of 118 AML patients in our center were analyzed and compared. NGS, mRNA and miRNA profiling and clinical data from 12 patients in TCGA database were integrative analyzed.…”
  3. 101403

    Data_Sheet_1_Population Structure and Spatial Distribution Pattern of Populus euphratica Riparian Forest Under Environmental Heterogeneity Along the Tarim River, Northwest China.pd... by Asadilla Yusup (12880919)

    Published 2022
    “…From the upper to the lower reaches, the average TH and CD decreased by 3.8 and 0.3 m, while the DBH increased by 4.2 cm. …”
  4. 101404
  5. 101405
  6. 101406
  7. 101407

    The Differentiation of Human Adipose-Derived Stem Cells towards a Urothelium-Like Phenotype <i>In Vitro</i> and the Dynamic Temporal Changes of Related Cytokines by Both Paracrine... by Ming Zhang (9736)

    Published 2014
    “…Array detection was used to screen 41 cytokines and receptors in the upper medium of urothelium, non-induced ASCs and urothelium-induced ASCs at three time points, early (12 hours), intermediate (7 days) and late (21 days).…”
  8. 101408
  9. 101409
  10. 101410

    Image_1_Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations.TIFF by Li Yang (6520)

    Published 2019
    “…</p><p>Methods: Next generation of sequencing (NGS) and clinical data of 118 AML patients in our center were analyzed and compared. NGS, mRNA and miRNA profiling and clinical data from 12 patients in TCGA database were integrative analyzed.…”
  11. 101411
  12. 101412
  13. 101413

    Detailed organic characterization of process water to evaluate reverse osmosis membrane fouling in industrial wastewater treatment by Minier-Matar, Joel

    Published 2024
    “…Bench-scale RO results showed that in the absence of ACF pretreatment, a 12 % decline in membrane permeability (from 1.78 to 1.57 L/(m2-bar-h)) was observed, while no permeability decline was measured after ACF treatment. …”
    Get full text
    Get full text
    Get full text
    article
  14. 101414

    The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats by Michaela Lang (117542)

    Published 2012
    “…The aims of this study were to investigate the role of NO–sGC–cGMP signaling in a model of severe PAH and to evaluate the effects of sGC stimulation by riociguat and PDE5 inhibition by sildenafil on pulmonary hemodynamics and vascular remodeling in severe experimental PAH.…”
  15. 101415

    Data_Sheet_1_Effects of Supplemental Leucine on Growth, Nutrient Use, and Muscle and Visceral Tissue Mass in Holstein Bull Calves Fed Milk Replacer.docx by Jessica N. Reiners (12176384)

    Published 2022
    “…<p>To determine the effects of leucine supplementation on body weight (BW), tissue mass, nutrient digestibility, the concentration of serum amino acids (AAs) and metabolites, and protein abundance of elongation initiation factor 4E (eIF4E) in skeletal muscle, 23 Holstein bull calves (43. 3 ± 1.16 kg; 11.3 ± 0.57 days of age) fed milk replacer at 2.5% of body weight (BW; dry matter basis) were used in a randomized complete block design. …”
  16. 101416

    JuliaCon2018 DataDeps.jl.pdf by Lyndon White (5615612)

    Published 2018
    “…</li><li><a href="https://github.com/oxinabox/InternedStrings.jl" rel="nofollow me noopener noreferrer" target="_blank">InternedStrings.jl</a> For decreasing memory usage, and speeding up equality checks.…”
  17. 101417

    Data_Sheet_1_Investigating the relationship between non-occupational pesticide exposure and metabolomic biomarkers.docx by Saranya Palaniswamy (11854188)

    Published 2023
    “…In women, OPE, PEM, and PEU were associated with decreased apolipoprotein A1 and increased apolipoprotein B/apolipoprotein A1 ratio. …”
  18. 101418

    Table_1_Maternal Conjugated Linoleic Acid Supply in Combination With or Without Essential Fatty Acids During Late Pregnancy and Early Lactation: Investigations on Physico-Chemical... by Wendy Liermann (9774182)

    Published 2022
    “…The current preliminary study investigated effects of a maternal fatty acid supplementation (MFAS) during transition period with coconut oil (CON, control), CLA (Lutalin®), or CLA + EFA (Lutalin® + essential fatty acids–linseed oil; safflower oil) on physico-chemical characteristics of jejunal content and microbiota of 5-day-old calves. …”
  19. 101419

    Datasets and metadata supporting the published article: BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression by Hanan S. Elsarraj (8473172)

    Published 2020
    “…</div><div> </div><div><b><br></b></div><div><b>Study aims and methodology: </b></div><div>The aim of the related study was to determine the molecular processes underlying progression to invasion in DCIS using PDX DCIS MIND animal models. Using a novel intraductal model they identify downregulation of specific STAT3 targets to promote progression and use a purified component from rosemary extract to show that treatment <i>in vivo</i> decreases DCIS progression in patient derived DCIS and cell line models.…”
  20. 101420

    Table_1_Pharmacokinetic and Pharmacogenetic Factors Contributing to Platelet Function Recovery After Single Dose of Ticagrelor in Healthy Subjects.DOCX by Qian Zhu (191342)

    Published 2019
    “…Effects of CYP2C19<sup>*</sup>2, CYP2C19<sup>*</sup>3, CYP3A5<sup>*</sup>3, UGT1A1<sup>*</sup>6, UGT1A1<sup>*</sup>28, UGT2B7<sup>*</sup>2, UGT2B7<sup>*</sup>3, SLCO1B1 388A>G, and SLCO1B1 521T>C, on the pharmacokinetics of ticagrelor and M8, and platelet function recovery were investigated.…”